Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹25 Cr₹167 Cr₹31 Cr₹-217 Cr₹-165 Cr

What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Financing Activities ratio of ORCHID PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹25 Cr
Mar2024₹167 Cr
Mar2023₹31 Cr
Mar2022₹-217 Cr
Mar2021₹-165 Cr

How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹25 Cr
-84.90
Mar2024 ₹167 Cr
435.97
Mar2023 ₹31 Cr
Positive
Mar2022 ₹-217 Cr
Negative
Mar2021 ₹-165 Cr -

Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,552.5 Cr -6.1% -22.1% -36% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-6.1%

-22.1%

-36%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses